PT  - JOURNAL ARTICLE
ED  - ,
TI  - ▾ Etodolac - a new NSAID for rheumatoid arthritis
AID  - 10.1136/dtb.25.3.11
DP  - 1987 Feb 09
TA  - Drug and Therapeutics Bulletin
PG  - 11--12
VI  - 25
IP  - 3
4099  - http://dtb.bmj.com/content/25/3/11.short
4100  - http://dtb.bmj.com/content/25/3/11.full
SO  - Drug Ther Bull1987 Feb 09; 25
AB  - Etodolac (Lodine-Ayerst; Ramodar-Wyeth) is the first new non-steroidal anti-inflammatory drug (NSAID) to be licensed in Britain for over three years. The licence is for use in rheumatoid arthritis (RA) only. Etodolac is claimed to be as effective as high-dose aspirin with no more unwanted effects than placebo. Does the clinical evidence support this claim?